Kim HooKim
Impact in
- Oncology top 10%
- Vascular Tumors and Angiosarcomas
- Pancreatic and Hepatic Oncology Research
-
- Sarcoma Diagnosis and Treatment
Papers in ⓘ
- Co-authors
- Michelle D. Reid (8 shared papers)Mark Edgar (2 shared papers)Harold C. Sullivan (2 shared papers)Stewart M. Knoepp (4 shared papers)C. M. S. Cohen (2 shared papers)Michael H. Roh (3 shared papers)Kristina Fields (2 shared papers)Oscar Lin (1 shared paper)
- Journals
- Cancer Cytopathology (5 papers)Diagnostic Cytopathology (4 papers)Therapeutic Advances in Urology (1 paper)Cell Death and Disease (1 paper)Journal of Lower Genital Tract Disease (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Kim HooKim
22 papers receiving 419 citations
Peers
Comparison fields: 5 of 55
- Oncology 246
- Pulmonary and Respiratory Medicine 155
- Cancer Research 52
- Endocrinology, Diabetes and Metabolism 54
- Cardiology and Cardiovascular Medicine 69
Countries citing papers authored by Kim HooKim
This map shows the geographic impact of Kim HooKim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim HooKim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim HooKim more than expected).
Fields of papers citing papers by Kim HooKim
This network shows the impact of papers produced by Kim HooKim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim HooKim. The network helps show where Kim HooKim may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim HooKim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 68 | |
| 2 | 2018 | 61 | |
| 3 | 2017 | 43 | |
| 4 | 2019 | 36 | |
| 5 | 2011 | 36 | |
| 6 | 2016 | 36 | |
| 7 | 2011 | 33 | |
| 8 | 2015 | 27 | |
| 9 | 2011 | 20 | |
| 10 | 2020 | 14 | |
| 11 | IgG anti-cardiomyocyte antibodies in giant cell myocarditis. | 2008 | 12 |
| 12 | 2019 | 9 | |
| 13 | 2019 | 8 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 5 | |
| 16 | 2016 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2013 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2024 | 1 |
About Kim HooKim
Kim HooKim is a scholar working on Oncology, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 23 papers that have together received 422 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (4 papers), Pancreatitis Pathology and Treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Melanoma and MAPK Pathways (2 papers), Viral-associated cancers and disorders (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Oncology (246 citations), Pulmonary and Respiratory Medicine (155 citations), Cancer Research (52 citations), Endocrinology, Diabetes and Metabolism (54 citations) and Cardiology and Cardiovascular Medicine (69 citations). Kim HooKim has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Michelle D. Reid, Mark Edgar, Harold C. Sullivan, Stewart M. Knoepp, C. M. S. Cohen, Michael H. Roh, Kristina Fields, Oscar Lin, Timothy J. Purwin and Inna Chervoneva. Their work appears in journals such as Cancer Cytopathology, Diagnostic Cytopathology, Therapeutic Advances in Urology, Cell Death and Disease and Journal of Lower Genital Tract Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.